An NADPH oxidase is thought to function in microglial cells of the central nervous system. These conclusions are based on pharmacological and immunochemical evidence, although these approaches are indirect and raise issues of specificity. For example, diphenyleneiodonium inhibits a variety of flavoenzymes, including xanthine oxidase, NADH dehydrogenase, and NADPH oxidase. Here, we provide genetic evidence that p47phox, an essential component of the phagocyte NADPH oxidase, is required for superoxide anion release from microglia. Microglia derived from newborn wild-type mice, but not from newborn p47phox-deficient ("knockout"; -/-) mice, produced superoxide after stimulation by opsonized zymosan or phorbol myristate acetate. Endogenous p47phox was detected only in wild-type microglia, consistent with selective superoxide production in these cells. Superoxide release was restored in p47phox-deficient microglia that were retrovirally transduced with human p47phox cDNA. Similar kinetics of superoxide generation were observed, consistent with the same enzyme functioning in wild-type and restored microglia. Immuno-detection of p47phox in transduced cells confirmed that restoration of superoxide release correlated with production of recombinant protein. These data provide genetic proof that p47phox is necessary for superoxide release by microglial cells and indicate that a system related to the phagocyte oxidase is active in these cells.
icroglia, the resident phagocytes of the central nervous system (CNS), display many of the same physical and functional characteristics as peripheral blood myeloid cells. Included among these are cell surface expression of CD45 (leukocyte common antigen) (1) and Fcγ receptor (FcγRI) (2) . As anti-infective phagocytes, microglial cells ingest, process, and present (through class I and class II major histocompatibility complex antigen expression) invading microorganisms for further attack by activated T cells (3, 4) . Fcγ mediates phagocytosis (5) and superoxide release (6) in microglia, which is reminiscent of its function in circulating neutrophils, monocytes, and tissue macrophages (7) . The ability of microglial cells to produce superoxide anions has potentially dichotomous effects in the CNS, however. Indeed, superoxide release from microglia may partially account for their proposed host defense and tissuedestructive roles in the brain (8) (9) (10) .
M
Chronic oxidative stress may be a significant etiological factor in a variety of neurodegenerative abnormalities, including Alzheimer's disease (11), Parkinson's disease (12, 13) , and multiple sclerosis (14) . Several reports have demonstrated that β-amyloid (β-A), a central component of the senile plaques associated with Alzheimer's disease, stimulates superoxide release from microglial cells (15) (16) (17) . These data imply that β-A deposition may not be the primary cause of neurodestruction in the CNS, but that it acts indirectly by stimulating superoxide release from microglia. Indeed, oxidative stress appears critical for promoting the phenotypic changes that characterize Alzheimer's disease progression, because anti-oxidant administration prevented the histopathologic and behavioral symptoms of Alzheimer's disease (18, 19) . Considering the phagocytic ability of microglia and other traits shared with circulating phagocytes, NADPH oxidase is a likely candidate responsible for reactive oxygen species (ROS) production in these cells.
Pharmacological and immunochemical evidence (17, 20) support the notion that an NADPH oxidase comprising a multi-component, flavocytochrome enzyme best characterized in circulating peripheral blood phagocytes (21) , also produces superoxide anions in microglia. However, these studies are not entirely conclusive because of concerns regarding the specificity of antibodies or inhibitors used. Other potential sources of superoxide production by microglia include xanthine oxidase, cyclooxygenases, lipoxygenases, and microsomal and mitochondrial electron transport chains.
To characterize further the source of ROS in microglial cells, we have explored the involvement of the phagocyte oxidase component, p47phox, by non-pharmacological means. A p47phox-deficient murine strain was created through targeted disruption of the p47phox gene (22) , which confers a chronic granulomatous disease (CGD) phenotype (i.e., enhanced susceptibility to bacterial and fungal infection and excess granuloma formation) due to a deficiency in superoxide generation by circulating phagocytes. In this report, we demonstrate an essential role for p47phox in superoxide release by microglia, through direct functional comparisons between cells derived from C57BL/6 wild-type (WT) and C57BL/6 p47phox-deficient (p47phox -/-; "knockout"; KO) mice. Furthermore, we show that the lack of superoxide release by microglia from p47phox-deficient mice is specifically due to p47phox deficiency, because retroviral transduction with a vector encoding human p47phox cDNA (23) restored superoxide production in p47phox-deficient cells. These novel results provide direct genetic proof that an essential component of the phagocyte NADPH oxidase is required to produce superoxide in microglia and they indicate that an NADPH oxidase related to the phagocyte system is functional in these cells.
MATERIALS AND METHODS

Derivation of murine microglial cells
Brain cortices were obtained from five 3-day-old wild-type (C57BL/6; WT) and p47phox-deficient (C57BL/6; KO) (22) mice 2-3 min following their kill by cervical dislocation. The tissues were dispersed into 100 mm 2 sterile petri dishes containing L-15 medium (Biofluids, Gaithersburg, Md.) supplemented with fungizone (Biofluids; 0.5 µg/ml). With the aid of a dissecting microscope and sterile forceps, the meninges were peeled from each of the cortices and blood vessels were removed. To promote tissue disruption, the cortices were pipetted up and down 10 times in a 10-ml pipette, followed by the same procedure in a 5-ml pipette. The tissues were centrifuged at 1100 x g for 5 min. Each tissue pellet was re-suspended into complete serum-containing medium: Dulbecco's minimum essential medium (Biofluids) containing 10% fetal bovine serum (HyClone, Logan, Utah), 1% glutamine (Biofluids), and 1% penicillin/streptomycin (Biofluids) and distributed into a T-75 cm 2 flask. Two weeks after seeding the brain tissues, a monolayer of fibroblast-like cells was observed underlying a more punctate-looking cell layer that adhered to the fibroblast-like monolayer. The mixed glial cell cultures were fractionated (see below) and harvested for experimentation no sooner than 2 weeks after tissue seeding.
Isolation and treatment of murine microglia
To prepare cells for superoxide assays, microglial cells derived from wild-type or p47phox-deficient mice were separated from more adherent fibroblast-like cells in the mixed glial cell cultures at 100% confluence by rotary shaking at 200 rpm for 1 h at room temperature. Some of the fibroblast-like cells were dislodged by shaking as well, but the majority (75%-95%) of cells included in the culture supernatant after shaking were microglial cells (see results). The microglial cell-enriched fraction was distributed in complete serum-containing medium into opaque 96-well microtiter chemiluminescence plates (Dynex Technologies, Chantilly, Va.) for superoxide assays (5 x 10 3 microglial cells/well) or to plastic chamber slides (Permanox R , Nalge Nunc International, Naperville, Ill.) for immuno-cytochemical staining (5 x 10 3 microglial cells/chamber).
To prepare cells for retroviral transduction, mixed glial cultures of each genotype were seeded into two T-75cm 2 flasks. After the fibroblast-like cells in each flask reached 90% confluence or greater, mixed glial cells from each genotype were transduced with the MFGS retrovirus containing human p47phox cDNA (23) and protamine (6 µg/ml) in X-VIVO 10 medium (BioWhittaker, Walkersville, Md.) diluted 1:1 with complete serum-containing medium. After the addition of viral supernatants, the cultures were spun at 525 x g for 20 min at 32°C to promote viral infection and incubated at 37°C for 8 h, after which time the media was changed to complete serum-containing medium for overnight incubation at 37°C. In negative controls, flasks of cells from each genotype received only complete serum (5 %)-containing medium with protamine. This procedure was repeated for 3 consecutive days. On the fifth day following seeding of mixed glial cell cultures, the microglial cell-enriched (less adherent) and fibroblastlike cell-enriched (more adherent) fractions were derived by shaking and trypsinization, respectively, for subsequent analyses by chemiluminescence and immunofluorescence assays.
Phase-contrast microscopy and indirect immunofluorescence microscopy
Freshly isolated cells of the microglia-enriched fraction or cells of the more adherent fibroblastlike layer were seeded onto eight-chamber plastic slides. Some of the cells were mounted and photographed by phase-contrast microscopy to illustrate their respective morphologies. Microglial cells were specifically stained for the presence of CD68 and p47phox, markers associated with differentiated myeloid cells. The fibroblast-like cells that were a minor component of microglial fractions were identified by staining for glial fibrillary acidic protein (GFAP), which is indicative of astrocytes. After a wash in 1X phosphate buffered saline (PBS; Biofluids), all cells were fixed and permeabilized in ice-cold methanol for 3 min and washed again. To block non-specific binding sites, the cells were incubated in a 1:4 dilution of normal rabbit serum (Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.) for 1 h at 37°C. For indirect immunofluorescence detection of p47phox, fixed microglial cells were incubated with specific goat polyclonal anti-p47 serum (1:200 of serum #1588 in 5% bovine serum albumin/PBS; BSA/PBS; 24) or normal goat serum (1:200; negative controls) for 60 min at 37°C. After 3 x 5 min washes with PBS, the cells were incubated with a lissamine-rhodamineconjugated rabbit anti-goat antibody (1:500; Jackson) for 60 min at 37°C. The cells were washed as described above and mounted for viewing. Goat-derived antibodies against CD68 (1:500) (Santa Cruz Biotechnology, Santa Cruz, Calif.) or GFAP (1:500) (Santa Cruz Biotechnology were prepared as dilutions in 5% BSA/PBS before their applications. All micrographs were produced with use of a Zeiss (Thornwood, NY) microscope.
Measurement of reactive oxygen species
Microglial cells from flasks of wild-type, p47phox-deficient, or transduced cultures were distributed onto sterile microtiter chemiluminescence plates (5 x 10 3 cells/well) for superoxide assays. After incubation overnight at 37°C, the cells were rinsed once with 1X Hank's balanced salt solution (HBBS) containing Ca 2+ and Mg 2+ before stimulation by reaction cocktails, which consisted of a superoxide-specific chemiluminescence indicator reagent (Diogenes, National Diagnostics, Atlanta, Ga.; 50% of total reaction volume), HBSS, and one of the following activators: (1) opsonized zymosan (OZ; 1 mg/ml) or (2) phorbol myristate acetate (PMA; Sigma, St. Louis, Mo.; 2 µg/ml). For OZ preparation, 20 mg of yeast zymosan A (Sigma) was incubated in 2 ml of human serum at 37°C for 1 h. After three washes in ice-cold PBS, the OZ was resuspended in 2 ml of PBS and stored at -20°C until needed. Superoxide dismutase-inhibitable chemiluminescence was detected in a luminometer (Labsystems Luminoskan; Helsinki, Finland) and expressed as the total integrated luminescence (relative light units; RLU) measured during each assay (0.5 second readings obtained at 1-min intervals over a time course of 40 min immediately after the addition of the reaction cocktails to the cells).
Statistical analyses
The mean of triplicate measurements of superoxide dismutase-inhibitable RLUs and the corresponding standard errors (indicated as bars above columns) of the means were calculated and used to indicate significant differences by two-tailed, paired t-tests or unequal variance tests (Mann-Whitney Rank Sum) where appropriate. A value of p < 0.05 indicated significant differences between means.
RESULTS
Microglial cell and astrocyte morphologies and surface antigens
Microglial cells and cells of the more adherent, fibroblast-like layer from each genotype were examined by phase-contrast microscopy and stained for a variety of cell-specific antigens by indirect immunofluorescence. Figure 1 shows microscopic images of wild-type (WT) and p47phox-deficient (KO) murine microglial cells (Figs. 1A-C) and astrocytes (Figs. 1D-F) . The majority of cells observed in the supernatant fraction of shaken cultures displayed characteristic bullet-shaped, pyramidal morphological features of microglia (WT, Fig. 1A and KO, Fig. 1B) . By indirect immunofluorescence, CD68 was detected in microglial cells (WT, Fig. 1C ). In contrast, cells that appeared more stellate and fibroblast-like had characteristic features of astrocytes (WT, Fig. 1D and KO, Fig. 1E ). GFAP was detected in the fibroblast-like cells observed in both microglia-enriched and astrocyte-enriched fractions derived from both WT and KO mice. Figure 1F shows that the suspended cell fraction derived from shaken mixed glial cultures contained a minority of GFAP-positive astrocytes, with the majority of unstained cells exhibiting microglial cell morphologies. These data support the identity of predominantly microglia in the supernatant fraction of shaken cultures. No discernable differences in morphology were observed between these genotypically different cell cultures.
Microglia from p47phox-deficient mice exhibit a deficiency in oxidative responses
Both neutrophils and microglial cells produce superoxide in response to β-A (15-17), OZ (6) or PMA (6, 25) . Our objective was to determine whether the genetic deficiency of p47phox, an essential component of the phagocyte NADPH oxidase, renders microglial cells unable to produce superoxide in response to these agonists. Both PMA and OZ elicited significant superoxide release by WT microglia, while essentially no activity was observed in the corresponding KO microglial cell cultures. PMA ( Fig. 2A) caused the greatest production of superoxide, with maximum activity occurring between 10 and 15 min after stimulation. Superoxide release by WT microglia in response to OZ (Fig. 2B ) displayed monophasic kinetics within the same time frame.
We also examined PMA-stimulated superoxide release by the more adherent, astrocyte-enriched fractions and observed significantly lower levels of superoxide produced by WT cultures, compared with its microglia-enriched counterpart, and essentially no activity in the KO adherent cell fractions (not shown). These results were consistent with the microglial cell content detected in the adherent cell fractions (in this experiment, approximately 25% determined by phase and immunofluorescence microscopy in both WT and KO cultures). Consistent with these observations, several groups reported that astrocytes do not produce superoxide in response to either PMA or OZ (6, 26, 27) . Therefore, the responses to these agonists, which were seen only in WT cultures, were attributed to the activity of microglial cells. Furthermore, the loss of function observed in KO cultures was not attributed to variability in culture compositions, because KO and WT microglial cultures had identical compositions in each of these experiments where superoxide production was assayed (not shown).
Detection of p47phox in wild-type microglial cells
To correlate the p47phox genotype with differences in oxidative capacities observed in microglial cultures from WT and KO mice, we examined these cultures for production of p47phox by indirect immunofluorescence. Specific detection of p47phox in microglial cells derived from WT mice (Fig. 3A) , but not in those from KO mice (Fig. 3B) , confirmed that p47phox was produced only in WT microglial cells. The p47phox-staining appeared as a diffuse cytoplasmic pattern with greatest intensity within perinuclear regions of WT cells, while the KO microglia did not stain positively. Only weak, nonspecific secondary antibody staining of astrocytes was observed in KO cultures. The detection of p47phox only in WT cells suggested but did not prove that the absence of p47phox was the sole factor causing the difference in superoxide generation between WT and KO microglial cell cultures. Functional restoration of oxidase activity after genetic transduction with p47phox retrovirus was pursued in order to prove that p47phox was necessary for superoxide release by microglial cells.
p47phox restores superoxide release in p47phox-deficient microglial cells
Because of its established role as an essential component of the phagocyte NADPH oxidase, the presence of p47phox in WT microglia suggested that this protein also participates in superoxide production in these cells. To investigate this possibility further, we tested microglia derived from p47phox-deficient mixed glial cell cultures that were transduced with a retrovirus (KO+) containing the human p47phox cDNA (23) . Figure 4A indicates that this procedure significantly restored superoxide production in these cells under OZ-or PMA-stimulated conditions, while the untransduced p47phox-deficient (KO) cells yielded superoxide levels that were essentially equivalent to background levels shown in Figure 2 . In agreement with previous observations (Fig. 2 and ref. 6 ), PMA was a stronger stimulus of superoxide production than was OZ in these corrected microglial cell cultures, although the levels of correction were still less than that observed in untransduced WT microglia (Fig. 4B) . It is interesting that transduction of WT cells (WT+; Fig. 4B ) also resulted in enhanced superoxide release, which is consistent with observations in immature phagocyte progeny derived from p47phox-transduced hematopoietic progenitor cells (H. L. Malech, unpublished observations). These data provide a novel genetic demonstration that p47phox participates in superoxide release from cultured murine microglial cells, likely serving as an essential component of an NADPH oxidase functionally related to the neutrophil system. The similar kinetics of OZ-induced superoxide production observed in transduced KO (Fig. 5A ), transduced WT (Fig. 5B) , and untransduced WT (Fig. 2B ) microglial cells provide further support for the notion that the same enzyme was functioning in all cases.
Recombinant p47phox expression in retrovirally transduced microglial cells
To correlate the restoration of superoxide release with production of recombinant p47phox, levels of p47phox were examined by immunofluorescence microscopy in the transduced microglial cell cultures and compared with untransduced cultures. Prior to retroviral transduction, p47phox was not detected in the p47phox-deficient (KO) cells (Fig. 3B) , which is consistent with their failure to produce superoxide. Figure 6B shows immunochemical detection of p47phox in p47phox-deficient microglial cells that were retrovirally transduced with recombinant p47phox (KO+). The intense immunofluorescence of microglial cells also evident in wild-type transduced cells (WT+; Fig. 6A ), relative to untransduced wild-type cells (WT; Fig.  3A) , indicated over-expression of recombinant p47phox at levels exceeding endogenous p47phox in WT cells. These observations correlate with the enhanced superoxide release observed in WT+ cells relative to WT cells (Fig. 4B) . Thus, functional recombinant p47phox not only enabled p47phox-deficient cells to produce superoxide (Fig. 4A ), but also promoted significant increases in superoxide release from WT+ cells compared with the WT cells (Fig. 4B) , demonstrating that p47phox is necessary for superoxide release by these murine microglia. These micrographs also reveal that astrocytes, which were detected in these microglial-enriched fractions, were transduced with recombinant p47phox.
DISCUSSION
This investigation conclusively shows that p47phox participates in superoxide anion generation from cultured murine microglial cells. For the first time, direct comparisons between wild-type and p47phox-deficient microglial cells have demonstrated significant differences in superoxide production in response to PMA or OZ. Immunocytochemical detection of p47phox only in wildtype cells suggested that the absence of this protein in p47phox-deficient microglia was responsible for the inability of these cells to produce superoxide. Accordingly, transduction of p47phox-deficient cells with a retrovirus containing the human p47phox cDNA was sufficient to restore superoxide release in these cells, and restoration of superoxide production correlated with detection of recombinant p47phox in these cells. Furthermore, enhanced expression of p47phox following transduction of wild-type microglia also resulted in supernormal production of superoxide. The kinetics of superoxide production observed following activation with OZ were similar in both the untransduced wild-type and the genetically reconstituted cultures, consistent with the same enzyme functioning in each of these cultures.
The importance of this study is threefold. First, these findings represent the first nonpharmacological evidence indicating that a 'phagocyte-like' NADPH oxidase is operative in microglia and can serve as a source of ROS in the brain. Second, these experiments demonstrate the function and genetic origin of p47phox in microglial cells. Finally, these data suggest that p47phox-deficient CGD patients may be at reduced risk for oxidative damage in the brain, but could be deficient in an as-yet-unknown physiological manifestation of NADPH oxidase function (i.e., brain development). Additional studies are required to determine if p47phox interacts with other genuine phox components or with their homologues to produce superoxide in microglia.
The phagocyte enzyme is composed of five essential components, including gp91phox (phagocyte oxidase), p22phox, p47phox, p67phox, and Rac 1 (macrophages) or Rac 2 (neutrophils) (21) . Both gp91phox and p22phox comprise membrane-imbedded subunits of flavocytochrome b558, while the latter three are cytosolic components that translocate and assemble with the cytochrome at the phagolysosomal or plasma membrane upon activation, thereby initiating transfer of electrons from cytosolic NADPH to molecular oxygen and production of superoxide anion. gp91phox is regarded as the central, core component of the enzyme, because electron transfer occurs among co-factors associated with this polypeptide (FAD and two hemes). p47phox and other cytosolic components are considered necessary cofactors that regulate the activity of the flavocytochome, but do not by themselves generate ROS (21) . Thus, the effects of p47phox transduction in the oxidase-deficient microglia suggest the presence of other essential oxidase components in these cells. Oxidase activation in microglia by β-A (15-17), OZ (6), or PMA (6, 25) , agonists that promote NADPH oxidase activity in circulating phagocytes, and its potentiation by interferon-γ and tumor necrosis factor-α (17, 28) , are other indications that the phagocyte oxidase may function in microglia. Furthermore, superoxide generation in sheep microglia was blocked by diphenylene-iodonium (DPI), a flavoenzyme inhibitor, and a 91-kDa membrane protein was detected in lysates of these cells with antibody against gp91phox (20) . Finally, an immunoreactive homologue of p22phox was detected in these cells, although this peptide exhibited an apparent molecular mass of ~29 kDa.
Although these data suggest that an NADPH oxidase produces superoxide in microglial cells, they remain inconclusive because iodonium compounds inhibit a variety of other flavoprotein enzymes, including NADH dehydrogenase (29) , NO synthase (30) , and xanthine oxidase (31) , and recognition of common epitopes does not establish common genetic origins of these antigens with genuine phox components. Although results from former studies are consistent with the effects of diphenyleneiodonium on the peripheral blood phagocyte oxidase, it has been unclear whether the same enzyme was inhibited in microglial cells because the functional NADPH oxidase components in microglia have not been well-characterized, as they have been in circulating phagocytes (21) . Thus, information regarding the genetic origins of the enzyme that releases superoxide from microglia is necessary to definitively determine whether an enzyme identical to the phagocyte NADPH oxidase functions in these cells.
Although it is thought that microglial cells share common ontogenic origins with other circulating myeloid cells such as neutrophils, monocytes, macrophages, and eosinophils, several other oxidases related to the phagocyte system have now been recognized. For example, the flavocytochrome component in skin fibroblasts and phagocytes differ both genetically and biochemically (32) , because gp91phox-deficient X-CGD patients who lack a functional oxidase in their phagocytic cells exhibit normal oxidative output in their fibroblasts. It appears that these cells harbor a distinct isotype of this core oxidase component, which is subject to different activation mechanisms. We have recently identified a distinct gp91phox homologue expressed in the kidney, called Renox, which was proposed to serve as an oxygen sensor (33), while Lambeth and colleagues have also described another homologue (Mox1) that is abundantly expressed in the colon (34) . Both Renox and Mox are capable of inducing superoxide release in transfected fibroblasts. Furthermore, a third gp91phox homologue has been identified in thyroid tissue (p138 Tox ), which is thought to serve in biosynthesis of thyroxin (35) . However, neither the Renox nor Mox transcript has been detected in brain, and it is unclear whether p47phox interacts with any of these gp91phox homologues. Work is in progress to examine whether microglial cells derived from the gp91phox-deficient mouse (36) produce superoxide anions.
The regulation of NADPH oxidase activity in microglia and circulating phagocytes has several striking similarities, since G i proteins, phosphatidylinositol-3 kinase, and tyrosine kinases seem to be common mediators (17) and p47phox appears to be a common essential component of both systems. Taken together, the current literature indicates that specific pharmacological manipulation of ROS production by microglia requires further examination to explore whether any biochemical differences exist between the structure and activation of NADPH oxidase in the brain and that in circulating phagocytes.
The cell-type that contributes most significantly to ROS production in the brain in response to injury or pro-inflammatory conditions remains unclear, although microglia appear to be early reactants to such events (9) . It is possible that ROS derived from stimulated microglia impose the initial insults, while subsequent ROS production is derived from peripherally circulating neutrophils and monocytes. By performing a series of allografts between wild-type and gp91phox-deficient mice, researchers showed that gp91phox expressed in both brain parenchymal cells and in circulating phagocytes contributes significantly to cerebral ischemiareperfusion-mediated injury (37) . However, this study did not delineate what resident brain cells were involved. Recent work using cultured gp91phox-deficient sympathetic neurons suggests that a neuronal NADPH oxidase contributes directly to neurodegeneration following nervegrowth factor deprivation (38) . However, it is not known whether NADPH oxidase exists in cerebral neurons and if so, whether it becomes activated during cerebral ischemia-reperfusion. The microglial oxidase may be activated following ischemia-reperfusion, because cultured microglia produce enhanced amounts of superoxide following serial exposures to hypoxia and reoxygenation (39) . These results, combined with the findings of this report, suggest that ischemia-reperfusion events in the brain may stimulate the microglial NADPH oxidase to produce ROS.
In conclusion, the current report provides significant new information regarding the origin of superoxide production in the brain. Regardless of their ontogenic origin, microglia can produce significant amounts of superoxide and nitric oxide (6, 25, (40) (41) (42) . The ability of microglia to liberate ROS have made them suspected contributors to a variety of brain diseases. Increasing evidence, such as the genetic proof provided here, indicates that the NADPH oxidase of microglia is likely a major source of ROS in the brain, particularly in response to injury and inflammatory stimuli. Further investigations are required to confirm these notions and, if true, whether modulation of this microglial cell activity can alter the development and course of neurological degenerative diseases. production. Mixed glial cell cultures derived from wild-type (WT) and KO mice were transduced with an MFGS retrovirus containing human p47phox cDNA (23) . Negative control cells from each genotype received complete medium without retrovirus. After these treatments, microglial cells were isolated from KO (A), transduced KO (KO+) (A), WT (B), and transduced WT (WT+) (B) mixed glial cell cultures, distributed to a chemiluminescence plate, and assayed for superoxide release in response to opsonized zymosan (OZ; 1 mg/ml) or phorbol myristate acetate (PMA; 2 µg/ml). Numbers shown on the ordinate indicate the mean of triplicate measurements of superoxide production indicated as superoxide dismutase-inhibitable relative light units (RLU) detected by the luminometer. Data shown represent three independent experiments performed with each agonist. (Fig. 3B) . Photographs are magnified at 200x.
